{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:57:45Z","timestamp":1783461465347,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":35,"publisher":"Springer US","isbn-type":[{"value":"9781071621479","type":"print"},{"value":"9781071621486","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2148-6_12","type":"book-chapter","created":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T03:55:42Z","timestamp":1641009342000},"page":"193-206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Glycan Microarrays Containing Synthetic Streptococcus pneumoniae CPS Fragments and Their Application to Vaccine Development"],"prefix":"10.1007","author":[{"given":"Paulina","family":"Kaplonek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Seeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"12_CR1","unstructured":"Centers for Disease Control and Prevention (2016). Active Bacterial Core Surveillance (ABCs) Report: Emerging Infections Program Network, Streptococcus pneumoniae"},{"issue":"3","key":"12_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01318-17","volume":"56","author":"CMC Rodrigues","year":"2018","unstructured":"Rodrigues CMC, Groves H (2018) Community-acquired pneumonia in children: the challenges of microbiological diagnosis. J Clin Microbiol 56(3):e01318-17. https:\/\/doi.org\/10.1128\/jcm.01318-17","journal-title":"J Clin Microbiol"},{"key":"12_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/628963","volume":"2008","author":"P Klein Klouwenberg","year":"2008","unstructured":"Klein Klouwenberg P, Bont L (2008) Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines. Clin Dev Immunol 2008:628963. https:\/\/doi.org\/10.1155\/2008\/628963","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"12_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2018.1451810","volume":"14","author":"AW Dretler","year":"2018","unstructured":"Dretler AW, Rouphael NG, Stephens DS (2018) Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Hum Vaccin Immunother 14(5):1\u201335. https:\/\/doi.org\/10.1080\/21645515.2018.1451810","journal-title":"Hum Vaccin Immunother"},{"key":"12_CR5","unstructured":"Society AT (2018). https:\/\/www.lung.org\/assets\/documents\/research\/pi-trend-report.pdf"},{"issue":"6","key":"12_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/mcc.0000000000000550","volume":"24","author":"C Cilloniz","year":"2018","unstructured":"Cilloniz C, Dominedo C, Garcia-Vidal C, Torres A (2018) Community-acquired pneumonia as an emergency condition. Curr Opin Crit Care 24(6):531\u2013539. https:\/\/doi.org\/10.1097\/mcc.0000000000000550","journal-title":"Curr Opin Crit Care"},{"key":"12_CR7","volume-title":"Levels & trends in child mortality report 2017","author":"UNICEF","year":"2017","unstructured":"UNICEF (2017) Levels & trends in child mortality report 2017. The United Nations Children\u2019s Fund, New York"},{"issue":"12","key":"12_CR8","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1128\/iai.00724-13","volume":"81","author":"Y Li","year":"2013","unstructured":"Li Y, Weinberger DM, Thompson CM, Trzcinski K, Lipsitch M (2013) Surface charge of Streptococcus pneumoniae predicts serotype distribution. Infect Immun 81(12):4519\u20134524. https:\/\/doi.org\/10.1128\/iai.00724-13","journal-title":"Infect Immun"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1749-6632.2012.06673.x","volume":"1263","author":"WC Gruber","year":"2012","unstructured":"Gruber WC, Scott DA, Emini EA (2012) Development and clinical evaluation of Prevnar 13, a 13-valent pneumococcal CRM197 conjugate vaccine. Ann N Y Acad Sci 1263:15\u201326. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06673.x","journal-title":"Ann N Y Acad Sci"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/B978-0-323-40181-4.00123-7","volume-title":"Principles and practice of pediatric infectious diseases","author":"K Ampofo","year":"2018","unstructured":"Ampofo K, Byington CL (2018) 123\u2014Streptococcus pneumoniae. In: Long SS, Prober CG, Fischer M (eds) Principles and practice of pediatric infectious diseases, 5th edn. Elsevier, pp 737\u2013746.e734. https:\/\/doi.org\/10.1016\/B978-0-323-40181-4.00123-7","edition":"5"},{"issue":"3","key":"12_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/cmr.00024-15","volume":"28","author":"KA Geno","year":"2015","unstructured":"Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, Konradsen HB, Nahm MH (2015) Pneumococcal capsules and their types: past, present, and future. Clin Microbiol Rev 28(3):871\u2013899. https:\/\/doi.org\/10.1128\/cmr.00024-15","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"12_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.17294\/2330-0698.1214","volume":"3","author":"S Hayward","year":"2016","unstructured":"Hayward S, Thompson LA, McEachern A (2016) Is 13-valent pneumococcal conjugate vaccine (PCV13) combined with 23-valent pneumococcal polysaccharide vaccine (PPSV23) superior to PPSV23 alone for reducing incidence or severity of pneumonia in older adults? A Clin-IQ. J Patient-Centered Res Rev 3(2):111\u2013115. https:\/\/doi.org\/10.17294\/2330-0698.1214","journal-title":"J Patient-Centered Res Rev"},{"issue":"1","key":"12_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/14712598.2018.1384462","volume":"18","author":"N Principi","year":"2018","unstructured":"Principi N, Esposito S (2018) Development of pneumococcal vaccines over the last 10 years. Expert Opin Biol Ther 18(1):7\u201317. https:\/\/doi.org\/10.1080\/14712598.2018.1384462","journal-title":"Expert Opin Biol Ther"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/bs.ampbs.2014.08.004","volume-title":"Advances in microbial physiology","author":"J Cole","year":"2014","unstructured":"Cole J, Aberdein J, Jubrail J, Dockrell DH (2014) Chapter Four\u2014the role of macrophages in the innate immune response to Streptococcus pneumoniae and Staphylococcus aureus: mechanisms and contrasts. In: Poole RK (ed) Advances in microbial physiology, vol 65. Academic, pp 125\u2013202. https:\/\/doi.org\/10.1016\/bs.ampbs.2014.08.004"},{"issue":"10","key":"12_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","volume":"11","author":"E Miller","year":"2011","unstructured":"Miller E, Andrews NJ, Waight PA, Slack MPE, George RC (2011) Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 11(10):760\u2013768. https:\/\/doi.org\/10.1016\/S1473-3099(11)70090-1","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"12_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3978\/j.issn.2305-5839.2014.02.07","volume":"2","author":"A Synytsya","year":"2014","unstructured":"Synytsya A, Novak M (2014) Structural analysis of glucans. Ann Transl Med 2(2):17. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2014.02.07","journal-title":"Ann Transl Med"},{"key":"12_CR17","volume-title":"Recommendations for the production and control of Haemophilus influenzae type b conjugate vaccines, volume 897","author":"WHO","year":"2000","unstructured":"WHO (2000) Recommendations for the production and control of Haemophilus influenzae type b conjugate vaccines, volume 897. WHO"},{"issue":"14","key":"12_CR18","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1021\/jacs.9b00638","volume":"141","author":"M Guberman","year":"2019","unstructured":"Guberman M, Seeberger PH (2019) Automated glycan assembly: a perspective. J Am Chem Soc 141(14):5581\u20135592. https:\/\/doi.org\/10.1021\/jacs.9b00638","journal-title":"J Am Chem Soc"},{"issue":"6","key":"12_CR19","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1073\/pnas.1800853116","volume":"116","author":"A Geissner","year":"2019","unstructured":"Geissner A, Reinhardt A, Rademacher C, Johannssen T, Monteiro J, Lepenies B, Thepaut M, Fieschi F, Mrazkova J, Wimmerova M, Schuhmacher F, Gotze S, Grunstein D, Guo X, Hahm HS, Kandasamy J, Leonori D, Martin CE, Parameswarappa SG, Pasari S, Schlegel MK, Tanaka H, Xiao G, Yang Y, Pereira CL, Anish C, Seeberger PH (2019) Microbe-focused glycan array screening platform. Proc Natl Acad Sci U S A 116(6):1958\u20131967. https:\/\/doi.org\/10.1073\/pnas.1800853116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cbpa.2013.11.013","volume":"18","author":"A Geissner","year":"2014","unstructured":"Geissner A, Anish C, Seeberger PH (2014) Glycan arrays as tools for infectious disease research. Curr Opin Chem Biol 18:38\u201345. https:\/\/doi.org\/10.1016\/j.cbpa.2013.11.013","journal-title":"Curr Opin Chem Biol"},{"issue":"41","key":"12_CR21","doi-asserted-by":"publisher","first-page":"14783","DOI":"10.1021\/jacs.7b07836","volume":"139","author":"M Emmadi","year":"2017","unstructured":"Emmadi M, Khan N, Lykke L, Reppe K, Sharavathi GP, Lisboa MP, Wienhold SM, Witzenrath M, Pereira CL, Seeberger PH (2017) A Streptococcus pneumoniae type 2 oligosaccharide glycoconjugate elicits opsonic antibodies and is protective in an animal model of invasive pneumococcal disease. J Am Chem Soc 139(41):14783\u201314791. https:\/\/doi.org\/10.1021\/jacs.7b07836","journal-title":"J Am Chem Soc"},{"issue":"11","key":"12_CR22","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.chembiol.2016.09.016","volume":"23","author":"SG Parameswarappa","year":"2016","unstructured":"Parameswarappa SG, Reppe K, Geissner A, Menova P, Govindan S, Calow AD, Wahlbrink A, Weishaupt MW, Monnanda BP, Bell RL, Pirofski LA, Suttorp N, Sander LE, Witzenrath M, Pereira CL, Anish C, Seeberger PH (2016) A semi-synthetic oligosaccharide conjugate vaccine candidate confers protection against Streptococcus pneumoniae serotype 3 infection. Cell Chem Biol 23(11):1407\u20131416. https:\/\/doi.org\/10.1016\/j.chembiol.2016.09.016","journal-title":"Cell Chem Biol"},{"issue":"42","key":"12_CR23","doi-asserted-by":"publisher","first-page":"11063","DOI":"10.1073\/pnas.1706875114","volume":"114","author":"MP Lisboa","year":"2017","unstructured":"Lisboa MP, Khan N, Martin C, Xu FF, Reppe K, Geissner A, Govindan S, Witzenrath M, Pereira CL, Seeberger PH (2017) Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5. Proc Natl Acad Sci U S A 114(42):11063\u201311068. https:\/\/doi.org\/10.1073\/pnas.1706875114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"380","key":"12_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf5347","volume":"9","author":"B Schumann","year":"2017","unstructured":"Schumann B, Hahm HS, Parameswarappa SG, Reppe K, Wahlbrink A, Govindan S, Kaplonek P, Pirofski LA, Witzenrath M, Anish C, Pereira CL, Seeberger PH (2017) A semisynthetic Streptococcus pneumoniae serotype 8 glycoconjugate vaccine. Sci Transl Med 9(380):eaaf5347. https:\/\/doi.org\/10.1126\/scitranslmed.aaf5347","journal-title":"Sci Transl Med"},{"issue":"4","key":"12_CR25","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1172\/jci91192","volume":"127","author":"Z Polonskaya","year":"2017","unstructured":"Polonskaya Z, Deng S, Sarkar A, Kain L, Comellas-Aragones M, McKay CS, Kaczanowska K, Holt M, McBride R, Palomo V, Self KM, Taylor S, Irimia A, Mehta SR, Dan JM, Brigger M, Crotty S, Schoenberger SP, Paulson JC, Wilson IA, Savage PB, Finn MG, Teyton L (2017) T cells control the generation of nanomolar-affinity anti-glycan antibodies. J Clin Invest 127(4):1491\u20131504. https:\/\/doi.org\/10.1172\/jci91192","journal-title":"J Clin Invest"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fimmu.2017.00659","volume":"8","author":"EA Kurbatova","year":"2017","unstructured":"Kurbatova EA, Akhmatova NK, Akhmatova EA, Egorova NB, Yastrebova NE, Sukhova EV, Yashunsky DV, Tsvetkov YE, Gening ML, Nifantiev NE (2017) Neoglycoconjugate of tetrasaccharide representing one repeating unit of the Streptococcus pneumoniae type 14 capsular polysaccharide induces the production of opsonizing IgG1 antibodies and possesses the highest protective activity as compared to hexa- and octasaccharide conjugates. Front Immunol 8:659. https:\/\/doi.org\/10.3389\/fimmu.2017.00659","journal-title":"Front Immunol"},{"issue":"52","key":"12_CR27","doi-asserted-by":"publisher","first-page":"13353","DOI":"10.1073\/pnas.1811862115","volume":"115","author":"P Kaplonek","year":"2018","unstructured":"Kaplonek P, Khan N, Reppe K, Schumann B, Emmadi M, Lisboa MP, Xu FF, Calow ADJ, Parameswarappa SG, Witzenrath M, Pereira CL, Seeberger PH (2018) Improving vaccines against Streptococcus pneumoniae using synthetic glycans. Proc Natl Acad Sci U S A 115(52):13353\u201313358. https:\/\/doi.org\/10.1073\/pnas.1811862115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"12_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1073\/pnas.1816401115","volume":"116","author":"X Sun","year":"2019","unstructured":"Sun X, Stefanetti G, Berti F, Kasper DL (2019) Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines. Proc Natl Acad Sci 116(1):193\u2013198. https:\/\/doi.org\/10.1073\/pnas.1816401115","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"12_CR29","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1128\/iai.69.7.4698-4701.2001","volume":"69","author":"B Benaissa-Trouw","year":"2001","unstructured":"Benaissa-Trouw B, Lefeber DJ, Kamerling JP, Vliegenthart JF, Kraaijeveld K, Snippe H (2001) Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice. Infect Immun 69(7):4698\u20134701. https:\/\/doi.org\/10.1128\/iai.69.7.4698-4701.2001","journal-title":"Infect Immun"},{"issue":"10","key":"12_CR30","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1128\/iai.00472-08","volume":"76","author":"D Safari","year":"2008","unstructured":"Safari D, Dekker HA, Joosten JA, Michalik D, de Souza AC, Adamo R, Lahmann M, Sundgren A, Oscarson S, Kamerling JP, Snippe H (2008) Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14. Infect Immun 76(10):4615\u20134623. https:\/\/doi.org\/10.1128\/iai.00472-08","journal-title":"Infect Immun"},{"issue":"11","key":"12_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri1956","volume":"6","author":"SK Mazmanian","year":"2006","unstructured":"Mazmanian SK, Kasper DL (2006) The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol 6(11):849\u2013858. https:\/\/doi.org\/10.1038\/nri1956","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"12_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.smim.2013.05.005","volume":"25","author":"FY Avci","year":"2013","unstructured":"Avci FY, Li X, Tsuji M, Kasper DL (2013) Carbohydrates and T cells: a sweet twosome. Semin Immunol 25(2):146\u2013151. https:\/\/doi.org\/10.1016\/j.smim.2013.05.005","journal-title":"Semin Immunol"},{"issue":"24","key":"12_CR33","doi-asserted-by":"publisher","first-page":"9015","DOI":"10.1039\/c8cs00495a","volume":"47","author":"F Berti","year":"2018","unstructured":"Berti F, Adamo R (2018) Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modification. Chem Soc Rev 47(24):9015\u20139025. https:\/\/doi.org\/10.1039\/c8cs00495a","journal-title":"Chem Soc Rev"},{"issue":"10","key":"12_CR34","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/glycob\/cww062","volume":"26","author":"L Sun","year":"2016","unstructured":"Sun L, Middleton DR, Wantuch PL, Ozdilek A, Avci FY (2016) Carbohydrates as T-cell antigens with implications in health and disease. Glycobiology 26(10):1029\u20131040. https:\/\/doi.org\/10.1093\/glycob\/cww062","journal-title":"Glycobiology"},{"issue":"3","key":"12_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/femsre\/fuy011","volume":"42","author":"F Micoli","year":"2018","unstructured":"Micoli F, Costantino P, Adamo R (2018) Potential targets for next generation anti-microbial glycoconjugate vaccines. FEMS Microbiol Rev 42(3):388\u2013423. https:\/\/doi.org\/10.1093\/femsre\/fuy011","journal-title":"FEMS Microbiol Rev"}],"container-title":["Methods in Molecular Biology","Glycan Microarrays"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2148-6_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T01:59:27Z","timestamp":1662170367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2148-6_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071621479","9781071621486"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2148-6_12","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"1 January 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}